AidsAids Chat

AidsChat.com Treatment & Research Information

Innate partnership of HLlA-B and KIR3DL1 subtypes against HIV-1

by MP Martin, et al.
(05-23-2007) - Journal: Nature Genetics. 2007 May 13; E-publication ahead of print.

Authors and affililation: Martin MP, Qi Y, Gao X, Yamada E, Martin JN, Pereyra F, Colombo S, Brown EE, Shupert WL, Phair J, Goedert JJ, Buchbinder S, Kirk GD, Telenti A, Connors M, O'brien SJ, Walker BD, Parham P, Deeks SG, McVicar DW, Carrington M. Laboratory of Genomic Diversity, Science Applications International Corporation-Frederick, Inc., National Cancer Institute, Frederick, Maryland, USA.

PMID: 17496894

Allotypes of the natural killer (NK) cell receptor KIR3DL1 vary in both NK cell expression patterns and inhibitory capacity upon binding to their ligands, HLA-B Bw4 molecules, present on target cells. [Allotypes are different DNA codings that may occupy a given position on a chromosome.]

Using a sample size of over 1,500 human immunodeficiency virus (HIV)(+) individuals, we show that various distinct allelic combinations of the KIR3DL1 and HLA-B loci significantly and strongly influence both AIDS progression and plasma HIV RNA abundance in a consistent manner.

These genetic data correlate very well with previously defined functional differences that distinguish KIR3DL1 allotypes.

The various epistatic effects observed here for common, distinct KIR3DL1 and HLA-B Bw4 combinations are unprecedented with regard to any pair of genetic loci in human disease, and indicate that NK cells may have a critical role in the natural history of HIV infection.


©2000 ProHealth, Inc. Copyright Policy

Related Articles
Dr. David Bell Reports “Snippets of Wonderful Science that Caught My Attention,” from the 2008 International HHV-6 Conference  
http://www.aidschat.com/showarticle.cfm?ID=3014
Letters From Our Readers - Q&A Session 07-02-08  
http://www.aidschat.com/showarticle.cfm?ID=3012
UCLA – Trial of drug to improve cognition & function in adults with depression, ages 60 and older (not yet recruiting)  
http://www.aidschat.com/showarticle.cfm?ID=3013
NIH Depression Drug Trials Now Recruiting in 13 States  
http://www.aidschat.com/showarticle.cfm?ID=3000
Study suggests as little as one glass of milk a day can cut risk of kidney/heart disease 37%  
http://www.aidschat.com/showarticle.cfm?ID=3001
Related Information Resources

Treatment & Research Libraries, Support Groups,
News & Information, Chat & Message Boards,
News Bulletins, Product Shopping Online, Events,
Guest speakers, Conferences, Seminars, & More...

-----------------------------------------------------------------------
Chronic Fatigue & Fibromyalgia Resources | http://www.immunesupport.com
-----------------------------------------------------------------------
Alzheimers & Cognitive Resources | http://www.alzheimersupport.com
-----------------------------------------------------------------------
Arthritis & Pain Management Resources | http://www.arthritissupport.com
-----------------------------------------------------------------------
AIDS & HIV Community Resources | http://www.aidschat.com
-----------------------------------------------------------------------
Depression Community Resources | http://www.depressionchat.com
-----------------------------------------------------------------------
Diabetes Community Resources | http://www.diabeteschat.net
-----------------------------------------------------------------------
Parkinson's Community Resources | http://www.parkinsonschat.com
-----------------------------------------------------------------------


This site is brought to you by ProHealth, Inc.
For a full Aids Support site, please visit: ProHealthNetwork.com
©2008 ProHealth, Inc. All Rights Reserved.
 
Aids catalog
Aids Messageboards

Aids Chat

Aids News

Aids Store


Email this page
FREE Treatment & Research Newsletter
+ ProHealth, Inc Resources:
·Alzheimers

·
Arthritis

·
Chronic Fatigue Syndrome

·
Fibromyalgia

·
Immune Support for Fibromyalgia & Chronic Fatigue Syndrome